United States
Germany
Japan
United Kingdom
China
CD19 mouse monoclonal antibody, clone OTI3B10
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Products
CD19 mouse monoclonal antibody, clone UMAB103
| Applications | FC, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI3B10
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI1F2 (formerly 1F2)
| Applications | IF, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI2F6 (formerly 2F6)
| Applications | FC, IF, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone UMAB103
| Applications | FC, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI2G7 (formerly 2G7)
| Applications | IF, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI2D3 (formerly 2D3)
| Applications | IF, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | IF, IHC, WB |
| Reactivities | Human |
Anti-CD19 mouse monoclonal antibody, clone OTI5F3 (formerly 5F3)
| Applications | WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
CD19 mouse monoclonal antibody, clone OTI2F6 (formerly 2F6)
| Applications | FC, IF, WB |
| Reactivities | Human |
